Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04967222 · ClinicalTrials.gov registry record · NA
Cognitive Reappraisal Training for Borderline Personality
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04967222 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 60 participants.
The verdict
NCT04967222, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Previous work by the study group convinced the study team to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in concert with evidence-based treatments of BPD. The present proposal aims to refine and test a proposed clinical intervention for BPD patients, training in reappraisal-by-distancing, in terms of its ability to influence hypothesized neural and behavioral targets and, once that is established, to demonstrate its ability improve clinically relevant outcome measures.
Interventions
- BEHAVIORAL Cognitive Reappraisal by Distancing
- BEHAVIORAL Control Downregulate Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2024-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04967222
The ClinicalTrials.gov registry entry for NCT04967222 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Reappraisal by Distancing is the first listed.
NCT04967222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04967222 about?
NCT04967222 is a clinical study titled "Cognitive Reappraisal Training for Borderline Personality". Previous work by the study group convinced the study team to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in concert with evidence-based treatments of BPD. The present proposal aims to refine and test a propo...
What is the current status of trial NCT04967222?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-12-01. Estimated completion is 2024-06-03.
What interventions are being tested in trial NCT04967222?
The interventions under investigation include: Cognitive Reappraisal by Distancing (BEHAVIORAL), Control Downregulate Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT04967222?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.